BusinessIndoor Harvest Corp and Alamo CBD Enter Into Discussions to Combine and Ultimately Create Medical Cannabinoids Pharmaceutical GroupBy Nasdaq OMXJan 3, 2017, 6:40 PM UTC
BusinessOSE Immunotherapeutics signs a license option agreement with Servier to develop and commercialize the product Effi-7By Nasdaq OMXDec 27, 2016, 11:01 PM UTC
BusinessApricus Biosciences Announces the Launch of Vitaros® for the Treatment of Erectile Dysfunction in Lebanon by Elis PharmaceuticalsBy Nasdaq OMXDec 27, 2016, 12:00 PM UTC
BusinessAmerican Health Council Names Cynthia White, JD to Industry BoardBy Nasdaq OMXDec 23, 2016, 3:00 PM UTC
BusinessNeothetics Initiates Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous FatBy Nasdaq OMXDec 23, 2016, 1:00 PM UTC
BusinessMotif Bio plc Announces Conversion of Convertible Promissory Notes, PDMR Dealing and Total Voting RightsBy Nasdaq OMXDec 22, 2016, 1:49 PM UTC
BusinessKeryx Biopharmaceuticals to Webcast its Presentation at J.P. Morgan’s 35th Annual Healthcare Conference on January 11, 2017By Nasdaq OMXDec 22, 2016, 1:31 PM UTC
